Relationship of β-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice

Carcinogenesis

Volumn 20, Issue 4, 1999, Pages 635-640

  McEntee, Michael F ^a   Chiu, Chun Hung ^a   Whelan, Jay ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BCL 2; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; CYTOPLASM; IMMUNOHISTOCHEMISTRY; INTESTINE TUMOR; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE CANCER; TUMOR REGRESSION;

EID: 0033028647     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.4.635     Document Type: Article

References (39)

1. Powell, S.M., Zilz, N., Beazer-Barclay, Y., Bryan, T.M., Hamilton, S.R., Thibodeau, S.N., Vogelstein, B. and Kinzler, K.W. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
2. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
3. Miyoshi, Y., Ando, H., Nagase, H. et al. (1992) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. Natl Acad. Sci. USA, 89, 4452-4456.
4. Levy, D.B., Smith, K.J., Beazer-Barclay, Y., Hamilton, S.R., Vogelstein, B. and Kinzler, K.W. (1994) Inactivation of both APC alleles in human and mouse tumors. Cancer Res., 54, 5953-5958.
5. Polakis, P. (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim. Biophys. Acta, 1332, F127-F147.
6. Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1996) Apoptosis and APC in colorectal tumorigenesis. Proc. Natl Acad. Sci. USA, 93, 7950-7954.
7. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K.W. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 275, 1787-1790.
8. He, T.C. Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B. and Kinzlcr, K.W. (1998) Identification of c-myc as a target of the APC pathway. Science, 281, 1509-1512.
9. Inomata, M., Ochiai, A., Akimoto, S., Kitano, S. and Hirohashi, S. (1996) Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res., 56, 2213-2217.
10. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
11. Williams, C.S., Luongo, C. Radhika, A., Zhang, T., Lamps, L.W., Nanney, L.B., Beauchamp, R.D. and DuBois, R.N. (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111, 1134-1140.
12. Giardiello, F.M., Offerhaus, J.A., Tersmette, A.C., Hylind, L.M., Krush, A.J., Brensinger, J.D., Booker, S.V. and Hamilton, S.R. (1996) Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. Gut. 38, 578-581.
13. Chiu, C.H., McEntee, M.F. and Whelan, J. (1997) Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res., 57, 4267-4273.
14. Piazza, G.A., Kulchak Rahm, A.L., Krutzsch, M. et al. (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55, 3110-3116.
15. Shiff, S.J., Koutsos, M.I., Qiao, L. and Rigas, B. (1996) Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222, 179-188.
16. Boolbol, S.K., Dannenberg, A.J. Chadburn, A. et al. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56, 2556-2560.
17. Chan, T.A., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl Acad. Sci. USA. 95, 681-686.
18. Elder, D.J., Hague, A., Hicks, D.J. and Paraskeva, C. (1996) Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56, 2273-2276.
19. Piazza, G.A., Rahm, A.K., Finn, T.S., Fryer, B.H., Li, H., Stoumen, A.L., Pamukcu, R. and Ahnen, D.J (1997) Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest and p53 induction. Cancer Res., 57, 2452-2459.
20. Bronner, M.P., Culin, C. Reed, J.C. and Furth, E.E. (1995) The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am. J. Pathol., 146, 20-26.
21. Sinicrope, F.A., Ruan, S.B., Cleary, K.R., Stephens, L.C., Lee, J.J. and Levin, B. (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res., 55, 237-241.
22. Kaklamanis, L., Savage, A., Mortensen, N., Tsiotos, P., Doussis-Anagnostopoulou, I., Biddloph, S., Whitehouse, R., Harris, A.L. and Gatter, K.C. (1996) Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia. J. Pathol., 179, 10-14.
23. Tsujii, M. and DuBois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
24. Liu, X.H., Yao, S., Kirschenbaum, A. and Levine, A.C. (1998) NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58, 4245-4249.
25. Mahmoud, N.N., Boolbol, S.K., Bilinski, R.T., Martucci, C., Chadburn, A. and Bertagnolli, M.M. (1997) APC gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res., 57, 5045-5050.
26. Beazer-Barclay, Y. Levy, D.B., Moser, A.R., Dove, W.F., Hamilton, S.R., Vogelstein, B. and Kinzler, K.W. (1996) Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis, 17, 1757-1760.
27. Jacoby, R.F. Marshall, D.J., Newton, M.A. et al. (1996) Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56, 710-714.
28. Shoemaker, A.R., Gould, K.A., Luongo, C., Moser, A.R. and Dove, W.F. (1997) Studies of neoplasia in the Min mouse. Biochim. Biophys. Acta, 1332, F25-F48.
29. Δ716 knockout mice. Cancer Res., 57, 1644-1649.
30. Behrens, J., Jerchow, B.A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Wedlich, D. and Birchmeier, W. (1998) Functional interaction of an axin homolog.,conductin, with β-catenin, APC and GSK3β. Science, 280, 596-599.
31. Sheng, H., Shao, J., Morrow, J.D., Beauchamp, R.D. and DuBois, R.N. (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res., 58, 362-366.
32. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
33. Hanif, R., Pittas, A., Feng, Y., Koutsos, M.I., Qiao, L., Staiano-Coico, L., Shiff, S.J. and Rigas, B. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Binchem. Pharmacol., 52, 237-245.
34. Haimovitz, F.A., Kolesnick, R.N. and Fuks, Z. (1997) Ceramide signaling in apoptosis. Br. Med. Bull., 53, 539-553.
35. Zhang, J., Alter, N., Reed, J.C., Borner, C., Obeid, L.M. and Hannun, Y.A. (1996) Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl Acad. Sci. USA, 93, 5325-5328.
36. Jäättelä, M., Benedict, M., Tewari, M., Shayman, J.A. and Dixit, V.M. (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene, 10, 2297-2305.
37. Hockenbery, D.M., Zutter, M., Hickey, W., Nahm, M. and Korsmeyer, S.J. (1991) Bcl2 protein is topographically restricted in tissues characterized by apoptotic death. Proc. Natl Acad. Sci. USA. 88, 6961-6965.
38. Merritt, A.J., Potten, C.S., Watson, A.J., Loh, D.Y., Nakayama, K. and Hickman, J.A. (1995) Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J. Cell Sci., 108, 2261-2271.
39. Lu, Q.L., Poulsom, R., Wong, L. and Hanby, A.M. (1993) Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol., 169, 431-437.